These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 18064910)

  • 41. A tale on animal models of Parkinson's disease.
    Bezard E; Przedborski S
    Mov Disord; 2011 May; 26(6):993-1002. PubMed ID: 21626544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene-environment interactions in Parkinson's disease.
    Ross CA; Smith WW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S309-15. PubMed ID: 18267256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila.
    Park J; Kim Y; Chung J
    Dis Model Mech; 2009; 2(7-8):336-40. PubMed ID: 19553694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.
    Crotty S; Fitzgerald P; Tuohy E; Harris DM; Fisher A; Mandel A; Bolton AE; Sullivan AM; Nolan Y
    Eur J Neurosci; 2008 Jan; 27(2):294-300. PubMed ID: 18190522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide.
    Singh S; Dikshit M
    Brain Res Rev; 2007 Jun; 54(2):233-50. PubMed ID: 17408564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caenorhabditis elegans as a model system for Parkinson's disease.
    Schmidt E; Seifert M; Baumeister R
    Neurodegener Dis; 2007; 4(2-3):199-217. PubMed ID: 17596715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients.
    Huisman E; Uylings HB; Hoogland PV
    Mov Disord; 2008 Jul; 23(10):1407-13. PubMed ID: 18581481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
    Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
    J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of glucocorticoids and chronic stress on progression of Parkinson's disease.
    Kibel A; Drenjancević-Perić I
    Med Hypotheses; 2008 Dec; 71(6):952-6. PubMed ID: 18718724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.
    Pan T; Kondo S; Le W; Jankovic J
    Brain; 2008 Aug; 131(Pt 8):1969-78. PubMed ID: 18187492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The second brain and Parkinson's disease.
    Lebouvier T; Chaumette T; Paillusson S; Duyckaerts C; Bruley des Varannes S; Neunlist M; Derkinderen P
    Eur J Neurosci; 2009 Sep; 30(5):735-41. PubMed ID: 19712093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of cell death in experimental models of Parkinson's disease.
    Hirsch EC; Hunot S; Hartmann A
    Funct Neurol; 2000; 15(4):229-37. PubMed ID: 11213526
    [No Abstract]   [Full Text] [Related]  

  • 53. Levodopa delivery systems for the treatment of Parkinson's disease: an overview.
    Goole J; Amighi K
    Int J Pharm; 2009 Oct; 380(1-2):1-15. PubMed ID: 19651197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Modelling synucleinopathies in genetically modified animals--successes and failures].
    Ninkina NN; Ustiugov AA; Bukhman VL
    Mol Biol (Mosk); 2008; 42(5):840-55. PubMed ID: 18988533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neural repair strategies for Parkinson's disease: insights from primate models.
    Soderstrom K; O'Malley J; Steece-Collier K; Kordower JH
    Cell Transplant; 2006; 15(3):251-65. PubMed ID: 16719060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
    Locke CJ; Fox SA; Caldwell GA; Caldwell KA
    Neurosci Lett; 2008 Jul; 439(2):129-33. PubMed ID: 18514411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemical and Genetic Zebrafish Models to Define Mechanisms of and Treatments for Dopaminergic Neurodegeneration.
    Wasel O; Freeman JL
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Research in motion: the enigma of Parkinson's disease pathology spread.
    Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
    Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of Parkinson's disease.
    Hirsch EC; Jenner P; Przedborski S
    Mov Disord; 2013 Jan; 28(1):24-30. PubMed ID: 22927094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
    Lane EL; Soulet D; Vercammen L; Cenci MA; Brundin P
    Neurobiol Dis; 2008 Nov; 32(2):220-8. PubMed ID: 18675359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.